BioHarvest Sciences Inc. (BHST)

Market Cap	97.90M
Revenue (ttm)	25.19M
Net Income (ttm)	-12.91M
Shares Out	17.33M
EPS (ttm)	-0.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,547
Open	5.80
Previous Close	5.62
Day's Range	5.70 - 5.80
52-Week Range	0.00 - 7.38
Beta	1.33
Analysts	Strong Buy
Price Target	13.00 (+130.09%)
Earnings Date	May 15, 2025

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. The company is involved in research h, development, manufacturing, marketing and sales of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food, as well as manufacturing, marketing, and sales of science-based he...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Employees: 2
• Stock Exchange: NASDAQ
• Ticker Symbol: BHST
• Website: https://www.bioharvest.com

Financial Performance

In 2024, BioHarvest Sciences's revenue was $25.19 million, an increase of 98.77% compared to the previous year's $12.67 million. Losses were -$12.91 million, 2.78% more than in 2023.

Financial numbers in USD

Analyst Forecast

According to 2 analysts, the average rating for BHST stock is "Strong Buy." The 12-month stock price forecast is $13.0, which is an increase of 130.09% from the latest price.

Price Target

$13.0

(130.09% upside)

Analyst Consensus: Strong Buy